90 related articles for article (PubMed ID: 3957968)
1. A simple method to heparinize biological materials.
Noishiki Y; Miyata T
J Biomed Mater Res; 1986 Mar; 20(3):337-46. PubMed ID: 3957968
[TBL] [Abstract][Full Text] [Related]
2. Biological materials fixed with an epoxy compound: comparison of the effects with or without ionically bound heparin.
Sung HW; Shih JS
J Appl Biomater; 1995; 6(3):185-90. PubMed ID: 7492809
[TBL] [Abstract][Full Text] [Related]
3. A new method to give an antithrombogenicity to biological materials and its successful application to vascular grafts.
Miyata T; Noishiki Y; Matsumae M; Yamane Y
Trans Am Soc Artif Intern Organs; 1983; 29():363-8. PubMed ID: 6673254
[No Abstract] [Full Text] [Related]
4. Development of a soft, pliable, slow heparin release venous graft.
Noishiki Y; Yamane Y; Miyata T; Okoshi T; Tomizawa Y
ASAIO Trans; 1990; 36(3):M343-6. PubMed ID: 2252694
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of heparinized-collageno-elastic tubes.
Senatore F; Shankar H; Chen JH; Avantsa S; Feola M; Posteraro R; Blackwell E
J Biomed Mater Res; 1990 Jul; 24(7):939-57. PubMed ID: 2398079
[TBL] [Abstract][Full Text] [Related]
6. Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeads.
Malsch R; Melui D; Piazolo L; Harenberg J; Heene DL
Semin Thromb Hemost; 1997; 23(1):23-30. PubMed ID: 9156407
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antithrombogenicity of polyetherurethaneurea containing quaternary ammonium groups in the side chains and of the polymer/heparin complex.
Ito Y; Sisido M; Imanishi Y
J Biomed Mater Res; 1986 Sep; 20(7):1017-33. PubMed ID: 3760001
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes.
Ito Y; Sisido M; Imanishi Y
J Biomed Mater Res; 1986 Oct; 20(8):1157-77. PubMed ID: 3782177
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel polyaminoetherurethaneureas and development of antithrombogenic material by their chemical modifications.
Shibuta R; Tanaka M; Sisido M; Imanishi Y
J Biomed Mater Res; 1986 Sep; 20(7):971-87. PubMed ID: 3760013
[TBL] [Abstract][Full Text] [Related]
10. Some characteristics of collagen-heparin complex.
Raghunath K; Biswas G; Panduranga Rao K; Joseph KT; Chvapil M
J Biomed Mater Res; 1983 Jul; 17(4):613-21. PubMed ID: 6885842
[TBL] [Abstract][Full Text] [Related]
11. Covalently-bound heparin makes collagen thromboresistant.
Keuren JF; Wielders SJ; Driessen A; Verhoeven M; Hendriks M; Lindhout T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):613-7. PubMed ID: 14707039
[TBL] [Abstract][Full Text] [Related]
12. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
13. Healing characteristics of polymer-coated or collagen-treated Dacron grafts: an experimental porcine study.
Pärsson H; Jundzill W; Johansson K; Jonung T; Norgren L
Cardiovasc Surg; 1994 Apr; 2(2):242-8. PubMed ID: 8049955
[TBL] [Abstract][Full Text] [Related]
14. Modification of polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities.
Phaneuf MD; Quist WC; Bide MJ; LoGerfo FW
J Appl Biomater; 1995; 6(4):289-99. PubMed ID: 8589514
[TBL] [Abstract][Full Text] [Related]
15. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
16. A biodegradable antiadhesion collagen membrane with slow release heparin.
Miyata T; Fususe M; Yamane Y; Noishiki Y
ASAIO Trans; 1988; 34(3):687-91. PubMed ID: 3196585
[TBL] [Abstract][Full Text] [Related]
17. In vitro platelet adhesion and in vivo antithrombogenicity of heparinized polyetherurethaneureas.
Ito Y; Imanishi Y; Sisido M
Biomaterials; 1988 May; 9(3):235-40. PubMed ID: 3408794
[TBL] [Abstract][Full Text] [Related]
18. Antithrombogenic heparinized polyacrylonitrile copolymer.
Miyama H; Fujii N; Kuwano A; Nagaoka S; Mori Y; Noishiki Y
J Biomed Mater Res; 1986 Sep; 20(7):895-901. PubMed ID: 3760006
[TBL] [Abstract][Full Text] [Related]
19. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
[TBL] [Abstract][Full Text] [Related]
20. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
